XERIS PHARMACEUTICALS INC (XERS) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
5:21 pm
Sale
2021-12-3113GXERIS BIOPHARMA HLDGS INC
XERS
Sessa Capital (Master), L.P.3,259,804
2.400%
-3,347,296decrease
(-50.66%)
Filing
History
2021-07-12
08:29 am
Sale
2021-06-3013GXERIS PHARMACEUTICALS INC
XERS
BlackRock Inc.
BLK
1,684,166
2.500%
-1,963,052decrease
(-53.82%)
Filing
History